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ABSTRACT
The product of the Drosophila embryonic lethal
abnormal visual system is a conserved protein
(ELAV) necessary for normal neuronal differentiation
and maintenance. It possesses three RNA-binding
domains and is involved in the regulation of RNA
metabolism. The long elav 30-untranslated region
(30-UTR) is necessary for autoregulation. We used
RNA-binding assays and in vitro selection to identify
theELAVbestbindingsiteintheelav30-UTR.Thissite
resemblesELAV-bindingsitesidentifiedpreviouslyin
heterologous targets, both for its nucleotide
sequence and its significant affinity for ELAV (Kd
40 nM). This finding supports our model that elav
autoregulation depends upon direct interaction
between ELAV and elav RNA. We narrowed down
the best binding site to a 20 nt long sequence
A(U5)A(U3)G(U2)A(U6) in an alternative 30 exon. We
propose and test a model in which the regulated
use of this alternative 30 exon is involved in normal
elav regulation. Found in NEurons (FNE), another
neuronal RNA-binding protein paralogous to ELAV,
also binds this site. These observations provide a
molecular basis for the in vivo interactions reported
previously between elav and fne.
INTRODUCTION
TheDrosophilagene embryonic lethal abnormal visualsystem
(elav) encodes (ELAV) protein that is the founding member of
a familyofprimarilyneuronalRNA-bindingproteinsthatexist
in all metazoans (1). Proteins from this family contain three
RNA recognition motif (RRMs), with a long variable hinge
separating RRM2 from RRM3 (1). Proteins with RRMs typ-
ically interact with RNA, and act as post-transcriptional regu-
lators. In addition, RRM domains can also serve other
functions. For example the RRM of the Y14 protein, present
in complexes at exon junctions, forms heterodimers with the
Mago-nashi protein, (2,3). RRM–DNA interactions have also
been reported (4).
Drosophila ELAV is required for the normal differentiation
and maintenance of all neurons, appearing in postmitotic neur-
ons and persisting at all stages of development (1,5). A second
member of the family, RBP9 (6), is produced starting at the
third larval instar in all neurons, where its function remains
unclear. It is also present in the cytoplasm of cystocytes where
it is necessary for female fertility (7). The product of the third
paralogue, found in neurons (fne), is detected shortly after
ELAV with the same neuronal speciﬁcity, except that FNE
appears to be cytoplasmic, while ELAV and neuronal RBP9
are nuclear (8). Over-expression of FNE in neurons has
shown that the two paralogues elav and fne interact (8). In
vertebrates, HuR, one of four ELAV orthologues, is ubiquit-
ously expressed (9), while the other three are early markers of
neuronal differentiation, and persist in some mature neurons
(10). The importance of these proteins for neuronal plasticity
is reﬂected by their accumulation during acquisition of spatial
memory in neurons of the hyppocampus (11,12).
ELAV family proteins bind with a distinct preference to
U-rich sequences with apparent dissociation constants (Kd)i n
the 1–100 nM range (9,13–20). Modest poly(A) binding
(Kd 146 nM) by the RRM3 of HuD, HuC and HuR (the ver-
tebrate homologues) has also been described (21,22). The
crystal structure of RRM–RNA complexes have been determ-
ined both for the ﬁrst two RRMs of HuD (23) and for the two
RRMs of the Drosophila Sex lethal protein (SXL), which
resemble Drosophila ELAV (24). The pairs of RRMs of
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doi:10.1093/nar/gki942HuD and SXL proteins fold very similarly and are associated
with a single RNA molecule. Each RRM constitutes a binding
pocket for distinct regions of the RNA, without base pairing
(25). Conserved residues in the RRM, in particular in the two
characteristic ribonucleoprotein (RNP) motifs, make direct
nucleotide contacts relying upon speciﬁc recognition of
the bases (23). Individual RRMs can still interact with the
RNA target, but with decreased efﬁciency (19,20,26,27).
Comparison of known RNA–RRM structures indicates
that although the proteins adopt similar tertiary structures,
speciﬁc RNA molecules adopt diverse conformations and
orientations (23).
Functions in RNA stabilization, export and translation have
been assigned to the vertebrate Hu proteins [for instance
(28–33)], while RBP9 has been proposed to destabilize
RNA (7). Drosophila ELAV, through direct binding in the
vicinity of polyadenylation sites located in alternative introns,
promotes the accumulation of alternative forms of mRNAs
encoding alternative protein forms speciﬁc to or enriched in
neurons (14,16,34,35). In addition, we have shown that elav
autoregulates through a mechanism requiring its 30-untrans-
lated region (30-UTR) (36). Owing to this autoregulation, the
level of ELAV protein in neurons is independent of elav gene
dosage. Versions of the elav gene with a truncated 30-UTR do
not autoregulate, and ﬂies carrying two copies die, except for a
few escapers (36).
In order to obtain further insight into the mechanism of elav
autoregulation, the identiﬁcation of the ELAV best binding
site on the 30-UTR of its own RNA was crucial. For this
purpose, we used a customized version of in vitro selection
whose merit was to identify actual sequences, as opposed to
deﬁning artiﬁcial consensus sequences. We mapped the site, a
U-rich sequence, to an alternative 30 exon retained in a non-
coding mRNA that otherwise shares the upstream non-coding
exon of the functional elav mRNA. This binding site differs
from the ELAV-binding sites mapped previously in the introns
of nrg and ewg targets, since it is exonic and at a distance from
polyadenylation sites. However, it shares with the ewg and nrg
sites a similarly high U content and a low Kd (40 nM) for
ELAV association. This suggestsa dualmolecular function for
ELAV, respectively for autoregulation and the regulation of
the metabolism of other RNAs. We also found that individual
RRMs bind speciﬁc targets with different relative speciﬁcities,
suggesting that different pairs of RRMs may be responsible for
speciﬁc-target recognition. Finally, we found that FNE can
bind to the same targets as ELAV, providing a possible
molecular basis for previously described elav/fne interactions
in vivo.
MATERIALS AND METHODS
Fusion proteins
The 483 amino acid long ELAV contains an N-terminal Q-A
rich region (amino acids 26–126) and three RRMs. The 356
amino acid long FNE protein is very similar, with a 24 amino
acid long N-terminus upstream of the three RRMs (8). The
glutathione S-transferase (GST) gene fusion system (Pharma-
cia Biotech) was used to produce fusion proteins. Open
reading frames (ORFs), either as restriction fragments or as
PCR products, were cloned in-frame into pGEX-2T. After
sequencing of the cloning junctions and of the cloned PCR
products, the plasmids were used to produce proteins accord-
ing to the manufacturer’s instructions: GST-ELAV (residues
76–483), GST-RRM1 (residues 76–242), GST-RRM2 (resi-
dues 229–324), GST-RRM3 (residues 364–483) and GST-
FNE2 (residues 15–356), the latter being poorly soluble.
Construction of the elav 30-UTR RNA pool
A library was constructed by sonication of a 7.5 kb BamHI
(p7.5BB) genomic clone which included the elav stop codon
and the complete 30-UTR, containing sequences necessary for
elav autoregulation (36). The 100 bp fragments were gel
puriﬁed and ligated into a modiﬁed pUC18 vector whose
HindIII–EcoRI polylinker fragment had been replaced by a
new sequence introducing an EcoRV site for cloning, restric-
tion sites for insert manipulation and a T7 promotor. The
new sequence was generated by the annealing of two
61mer oligonucleotides AGCTAATACGACTCACTATAG-
GGAGCTCAGAATAAACGCTGATATCGACATGAGGC-
CCGG (Selex5) and AATTCCGGGCCTCATGTCGATAT-
CAGCGTTTATTCTGAGCTCCCTATAGTGAGTCGTAT-
TA (Selex6).
Independent clones (1500) were obtained after transforma-
tion, referred to as the original library (OL). The colonies on
thetransformation plates were recoveredinLuria–Bertani,and
the cell suspension was used to inoculate two 250 ml cultures.
The cultures were used to purify OL DNA. Characterization of
the library was performed by testing 24 independent clones:
18 of the clones contained an insert  100 nt long, 2 contained
a double insert and 3 none. Sequencing of three clones
revealed 73, 93 and 105 nt long inserts corresponding to dif-
ferent regions of the 30-UTR. In addition, Southern blot ana-
lysis of p7.5BB with a probe made from the OL DNA showed
that the library was representative (Results).
An aliquot of OL DNA was PCR ampliﬁed using the 23mer
CGAATTCCGGGCCTCATGTCGAT (Selex3) and the
48mer GCCAAGCTTAATACGACTCACTATAGGGAGC-
TCAGAATAAACGCTGAT (Selex4). The ampliﬁed DNA
(up to 4 mg DNA in 100 ml) was transcribed by T7 RNA
polymerase in 40 mM Tris, pH 7.9, 6 mM MgCl2,2m M
spermidine, 10 mM DTT, 0.5 mM each G-, A-, U-, CTP,
10
 3 mM [a-
32P]CTP 800 Ci/mmol (Amersham), 100 U RNa-
sin (Promega) and 25 U T7 RNA polymerase (Promega). After
1 h incubation at 37 C, the reaction was treated at 37 C for 150
with 5 U RQ1 DNase (Promega). Subsequent puriﬁcation on a
6% acrylamide, 7M urea gel (elution buffer: 2 mM EDTA and
500 mM ammonium acetate) yielded the ﬁrst poolofRNAsfor
partitioning. In these labelling conditions, n d.p.m./ml of puri-
ﬁed labelled RNA corresponds to a mM concentration of
[n · 2.8 10
 4/number of C residues in the RNA].
In vitro selection
We performed the partitioning between ELAV-bound and
-unbound RNAs using conditions that gave 1–5% RNA-
binding per cycle. The GST-ELAV concentration allowing
the desired percentage of binding was determined before
each cycle as follows: small-scale binding reactions (10 ml)
were set up between GST-ELAV (3 nM to 3.1 mM by serial
2-fold dilutions) and a pool of heat-denatured RNAs (25000
d.p.m.) in 110 mM NaCl, 20 mM Tris–HCl, pH 7.5, 2.5 mM
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DTT, 100 ng/ml tRNA, 0.6 U/ml RNasin (Promega) and 1%
glycerol. After a 15 min incubation at 37 C, the reactions were
ﬁltered on pre-wet nitrocellulose (Millipore HAWP 02500)
in a sampling manifold (Millipore XX2702550) as in (37).
The percentage of bound RNA was calculated as
follows: radioactivity retained on the ﬁlter ·100/radioactivity
(recovered in the ﬂow through + retained on the ﬁlter).
The reaction allowing the desired percentage binding was
scaled up (100–200 ml) for partitioning and the ELAV-bound
RNA was puriﬁed on nitrocellulose. The RNA was recovered
by incubation of the cut ﬁlter 30 min at room temperature with
200 ml of 10 M urea, 400 ml phenol, pH 7.6 and 200 ml
chloroform, recovery and re-extraction of the aqueous phase
with phenol/chloroform before ethanol precipitation. The
puriﬁed sample was annealed with 1.3 mg of Selex3
oligonucleotide in 40 ml of 20 mM Tris, pH 7.5 and 10
mM MgCl2. Reverse transcription was performed with Super-
script RNase H
  reverse transcriptase (Life Technologies)
according to the manufacturer’s instructions, in a 100 ml
reaction volume, of which 5% was removed before the
addition of RT, as a control.
Optimal conditions for PCR ampliﬁcation of the cDNA
were determined at each cycle as follows: four ampliﬁcation
reactions were set up in 50 ml, using as substrate (i) 5 mlo ft h e
cDNA obtained by reverse transcription, (ii) 5 ml of the control
reaction without RT, (iii) 1 ng OL DNA, and (iv) no substrate,
with 0.4 mg Selex3, 1 mg Selex4, 50 nM each dNTP in 50 mM
KCl, 10 mM Tris–HCl, pH9, 0.1% Triton X-100 and 1.5 mM
MgCl2. Each reaction was divided among four 12.5 ml tubes,
heated to 95 C for 5 min before addition of 0.6 U Taq DNA
polymerase (Promega) at 80 C, and ampliﬁcation was per-
formed by incubation for 1 min at 94 C, 1 min at 55 C,
1 min at 72 C for n cycles (n ¼ 8, 10, 12 and 14), followed
by 7 min at 72 C. The cycle number giving optimal ampli-
ﬁcation of the cDNA was used for a scaled up experiment.
The ampliﬁcation products were phenol-chloroform extracted
before ethanol precipitation and resuspension in 100 mlH 2O.
Subsequent T7 polymerase transcription and partitioning
cycles were performed in similar conditions.
Shift assays and binding curves
Labelled RNA was synthesized as above in a 10 ml reaction,
except that [a-
32P]UTP 800 Ci/mmol was used at a con-
centration 2.5 · 10
 4 mM. In these labelling conditions,
n d.p.m./ml of puriﬁed labelled RNA corresponds to a mM
concentration of [n · 1.125 10
 3/number of U residues in the
RNA]. The DNA ﬂanked by Selex3 and Selex4 sequences
(template concentration: 60 nM for PCR products or 2 nM
for HindIII plus EcoRI digested plasmid DNA) was tran-
scribed with T7 polymerase and gel puriﬁed as needed on
urea gels, followed by elution in 1% SDS, 25 mg/ml tRNA
and 500 mM ammonium acetate. For shift assays, labelled
RNA (1000–2000 d.p.m.) in 5 ml of 100 mM NaCl, 20 mM
Tris–HCl, pH 7.5 and 1 mg tRNA, was heated for 3 min at
85 C, and cooled on ice. Binding reactions (10 ml) between
heat-denatured RNA and proteins (as speciﬁed in each experi-
ment) were in 110 mM NaCl, 20 mM Tris–HCl, pH 7.5,
2.5 mM MgCl2, 2.5 mM KCl, 8 mM Na2HPO4,2m M
KH2PO4, 0.1 mg/ml tRNA, 3 mM DTT, 0.6 U/ml RNasin
(Promega) and 1% glycerol at 37 C for 15 min. Glycerol
dye (1 ml of 50% glycerol and 5% bromophenol blue) was
added to the reactions before analysis on a 0.75 cm thick
acrylamide/bis (80:1) gel run at 120 V in 0.5· TBE, and
dried before autoradiography.
Binding curves were established by nitrocellulose ﬁltra-
tion as above, except that GST-ELAV concentrations
were between 640 and 0.625 nM (2-fold dilutions) and
5000 d.p.m. of heat-denatured labelled RNAs were used.
Sequence data
After puriﬁcation with Wizard PCR Preps DNA puriﬁcation
system (Promega), aliquots of the PCR ampliﬁed cDNA deriv-
ing from selected RNAs were cloned into pGEM-T (Promega)
according to the manufacturer’s intructions. elav cDNA clone
RE58603 from the Berkeley Drosophila Genome Project (38)
was obtained from Invitrogen Life Technologies, and addi-
tional partial cDNAs were obtained as in (8). Sequencing was
performed on Applied Biosytems and Li-Cor sequencers by
the University of Nebraska Medical Center/Eppley Molecular
Biology core Facility or MWG Biotech. Sequence analysis
was performed with the GCG Wisconsin Package (Version
10.2; Genetics Computer Group, Madison, WI). The
LD33076 sequence was obtained from GenBank under acces-
sion number AY051822. We deposited the RE58603,
RE14370 and cDNA3h sequences under accession numbers
DQ004736, DQ243914 and DQ243913.
Generation of specific target RNAs
PCR ampliﬁcation was performed with pairs of oligonuc-
leotides framing the ELAV best binding sites respectively
in the elav 30-UTR (S11F, CTTGATGAAAATTTTAGCATC;
S11R, GAGAGGGAAACAAGTATAG; template, cloned
elav 30-UTR) and in a neuroglian intron (nrg1, CATATTTT-
GTGTTCCTTG; nrg2, GTGTTTATTTTACGTGTTTAG;
template, genomic DNA). Clones of the PCR products in
pGEM-T were modiﬁed (restriction digest followed by T4
polymerase repair before circularization) to reduce the region
between the start of transcription and the insert, and
sequenced. T7 transcripts were produced and puriﬁed as
above after linearization with NotI or RsaI.
Homoribopolymer binding assay
Proteins were incubated in 500 ml binding buffer 20 mM Tris–
HCl, pH 7.5, 2.5 mM MgCl2, 0.5% Triton X100, 0.1 M NaCl
for 10 min at 4 C with homoribopolymers bound to resins
(Sigma P 1908, P 5643, D 8563 and D 9827). The resins
were washed three times for 10 min at 4 C in binding buffer,
resuspendedin2·Laemmliloadingbuffer,incubatedfor5min
at 90 C before SDS–PAGE, followed by Coomassie blue
staining. Alternatively (for individual RRMs), the detection
was performed with a polyclonal antibody detecting the GST
moiety of the GST fusions proteins (anti-GST:FNE antibody).
Northern blot analysis and RT–PCR
Northern blot analysis was performed as in (8) using single-
stranded RNA (ssRNA) antisense probes. For RT–PCR, total
RNA (100 ng) extracted from six embryonic developmental
windows was reverse transcribed in 12.5 ml with AMV RT
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presence of 50 ng of downstream primer, namely EX3R for
elav coding transcript detection, EX4R for the detection of a
type of non-coding transcript (RE58603) or RP49R for the
control of RNA abundance. PCRs were performed on the
RT products using Taq DNA polymerase in the presence of
appropriate primer pairs: EX2F plus EX3R for the RT with
EX3R, yielding a350 bpproduct,EX2Fplus5599Rforthe RT
with EX4R (5599R anneals upstream of EX4R) yielding a
269 bp product, and RP49F plus RP49R, yielding a 364 bp
product. PCR products were analysed on agarose gels, and
aliquots of the elav RT–PCR products were sequenced for
veriﬁcation. EX2F, CGAAGCAGAGAGCAAGGA; EX3R,
GATTGCCTGTTGCACCTGT; EX4R, TCCTGTCCCACA-
GTGTGT; 5599R, TCCTTATATGCGGCTGCCT; RP49F,
ATCGATATGCTAAGCTGT; RP49R, ACGTTACAAGAA-
CTCTCA.
RESULTS
Iterative in vitro selection identifies the site
preferentially bound by ELAV in the elav 30-UTR
elav autoregulates through a mechanism requiring the elav
7 kb long 30-UTR (36). Given the ability of ELAV to bind
RNA, a plausible mechanism of regulation could rely upon
direct ELAV binding to the elav 30-UTR. To evaluate this
possibility, we decided to identify potential binding sites in
the elav 30-UTR.
We performed an iterative in vitro selection with GST-
ELAV as a target, and RNA obtained by transcription of a
library representative of the elav 30-UTR referred to as the
OL (Figure 1 and Materials and Methods). We chose this
customized approach, using as RNA targets actual genomic
Drosophila sequences, so that we could directly identify a
speciﬁc binding site rather than a consensus sequence,
which can be ambiguous. A somewhat similar approach
was used for iterative selection of Hel-NI (a human ELAV-
like protein) binding sequences, from libraries of naturally
occurring 30-UTR sequences (39).
The progress of the enrichment was monitored (i) by shift
assays, to assess the ability of given RNA populations to
associate with ELAV, (ii) by Southern blot analysis of the
genomicclone used togenerateOL, using labelledpopulations
of partitioned RNAs as probes, since the homogenization of
the RNA population is expected to lead to simpliﬁcation of the
hybridization pattern and (iii) by establishment of binding
curves (established by nitrocellulose ﬁltration) between
ELAV and the population of RNA, another means to evaluate
the afﬁnity of RNAs for ELAV (Figure 1). Based upon these
criteria, after two cycles, a dramatic change in the parti-
tioned RNA population proﬁle was observed and after three
additional cycles optimal enrichment was obtained (Figure 1A
and B).
We cloned and sequenced 12 cDNAs made from the par-
titioned RNAs of the last cycle (S5 clones). Insert sizes ranged
from 81 to 118 nt. Their sequences were grouped into three
non-overlapping clusters (Figure 1D and E). Cluster 1 (C1,
8 of 12 sequenced clones) spans 183 nt in the 30-UTR, with a
20 nt long overlap in region 12331–12350 of the elav 30-UTR.
Cluster 2 (C2, 2 of 12 sequenced clones) spans 103 nt, with an
overlap in region 9730–9830, and an insertion leading to 12
and 15 additional units, respectively, towards the 30 end of the
RNA. Cluster 3 (C3, 2 of 12 sequenced clones) covers 109 nt
with an overlap in region 11908–11987. The clones deﬁning
C1 and C3 encode sense 30-UTR RNA, while those deﬁning
C2 encode antisense 30-UTR RNA.
Shifts assays were performed with representative clones of
the three cluster types, and all demonstrate signiﬁcant ELAV
binding (Figure 1C and data not shown for C2 clones) con-
ﬁrming that the partitioned RNA population was selected on
the basis of its afﬁnity for ELAV.
C1 clones appear to encode the ELAV best binding site
because of their predominance. C2 clones encode artefactual
antisense RNA, and we excluded it as the target we were
looking for. C3 clones are signiﬁcantly less represented
than C1 clones in the ﬁnal partitioned pool 5 (Southern hybrid-
izations Figure 1A and C), but interestingly, in pool 2, C1 and
C3 clones were both signiﬁcantly represented (Figure 1A
and C). Although a second independent in vitro partitioning
did not provide evidence for enrichment of C3 type clones,
but only for type C1 clones, we do not exclude the possibility
that C3 clones might encode a secondary binding site
for ELAV.
ELAV binding to its best binding site in the
elav 30-UTR is sequence specific
The C1 clones show an overlap of 20 nt (AUUUUUAUUU-
GUUAUUUUUU; Figure 1D), that we refer to as selected site
for ELAV (SSE). By deduction, this sequence should deﬁne
the ELAV best binding site. To evaluate this possibility, we
examined the binding of ELAV to speciﬁc RNA targets
(Figure 2C). On shift assays (Figure 2A), ELAV similarly
binds SSE1F, a 120 nt long RNA including SSE, and
EXS6, a 135 nt long RNA including one of the four binding
sites for ELAV identiﬁed by cross-linking experiments in the
neuroglian gene (14). It also binds SSE1FD, a 65 nt long
truncated version of SSE1F including SSE (data not
shown). In contrast, it poorly binds SSE1R, the reverse com-
plement to SSE1F (Figure 2A). Interestingly, reproducible
patterns of multiple bands are seen, indicating that several
types of complexes are sequentially formed as ELAV concen-
tration increases (Figure 2A). We established the binding
curves of ELAV to the different RNA targets by nitrocellulose
ﬁltration, and found that SSE1F and EXS6 have comparable
afﬁnities for ELAV (Kd of  40 nM), while the antisense RNA
has a Kd greater than 1 mM (Figure 2B). Therefore, the 65 nt
RNA containing the SSE sequence is sufﬁcient for signiﬁcant
and speciﬁc ELAV binding. We further demonstrated the
sequence speciﬁcity of the ELAV–RNA interaction by show-
ing that poly(U) can compete for binding of ELAV to an SSE-
containing RNA, while poly(A) has no effect (Figure 3A).
Finally, we showed that a 20mer RNA oligonucleotide cor-
responding to SSE also competes the binding of ELAV to
SSE1F, while a mutated version of this RNA (SSE C, muta-
tion of the G to C) does not compete as efﬁciently (Figure 3B).
An 8-fold excess of cold SSE G competitor is sufﬁcient to
partially prevent binding, whereas the same excess of SSE C
has no effect. These experiments show that SSE is directly
bound by ELAV and demonstrate the sequence speciﬁcity of
its binding.
Nucleic Acids Research, 2005, Vol. 33, No. 19 6375Figure 1. Selection of the ELAV best binding site. (A) Upper panels: labelled RNAs (1000 d.p.m., 1.5–2 nM) were used in shift assays with GST-ELAV protein,
concentration in nM as indicated. The four panels are from the same experiment, run on two gels. Lower panels: Southern hybridizations to RsaI-, Sau3AI- or
AluI-digested p7.5BB, covering the elav 30-UTR sequence, are shown below the shifts. Molecular weight (bp) on the left. (B) Binding curve between GST-ELAV
protein and RNA pools or discrete RNA species. All experiments were performed in parallel with the same protein batch. (C) Tests by shift assays and Southern
hybridizationofrepresentativeclonesofclustersC1andC3whichwereidentifiedthroughpartitioning,asin(A).(D)Sequencecoveredbythethreenon-overlapping
clusters (C1, C2 and C3). In the scale from (E), C1, coordinates 12269–12451; C2, coordinates 9730–9832; C3, coordinates 11881–11989. The sequences
overlappingwithineach clusterare underlinedand a 12 Uinsertiontypical ofC2RNAs is bold. (E) Schematicsof the elav locus(B, BamHI;E, EcoRI;H, HindIII),
with a scale in kb at the bottom, as defined previously (48).Asterisks indicate the position of C1, C2 and C3. The span of the genomic fragmentsincluded in the TfS
andTfLminigenesisshown.TfSrescueelavfunction,butonlyTfLshowautoregulationofthegene.AlsoindicatedistheregionfromwhichtheOLwasmade.RNA
symbols:OL, originallibraryRNApool;Pool 2,RNApoolafter twopartitioningcycles;Pool 5,RNApoolafter fivepartitioningcycles;C1/SSE10andC1/SSE11,
RNAsfromC1clones,coordinates12270–12350and12331–12451,respectively.C3/SSE13,RNAfromaC3clone,coordinates11908–11987;OL#9,RNAfrom
an OL clone with a 50% GC content.
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RNA-binding specificities
We showed that ELAV similarly binds the nrg and elav RNA
targets. To determine if recognition of a speciﬁc target is
performed by speciﬁc RRM(s), we examined their binding
speciﬁcity. First, we used an assay that classiﬁes RNA-
binding proteins according to their binding properties to
homoribopolymers. In this assay, ELAV binds to homori-
bopolyuridylic acid and not to poly(A), poly(G) or poly(C),
although weak binding to poly(G) is detected at low salt con-
centration (100 mM NaCl) (8). We tested the individual RRMs
in this assay to evaluate their potential RNA-binding proper-
ties, and found that, similar to ELAV, both RRM1 and RRM3
bind poly(U) (Figure 4A and B). However, no binding was
observed for RRM2. In addition, weak poly(G) binding was
observed in the case of RRM1 (Figure 4B). Thus, the binding
speciﬁcity of individual RRMs to homoribopolymers in this
assay summarizes the speciﬁcity of ELAV essentially as a
poly(U) binding protein.
Toassessthespeciﬁcityofthebindingofthenrgsiteandthe
elav siteby individual RRMs we used them in shift assays with
a mixture of elav and nrg target RNAs whose sizes differ,
allowing simultaneous monitoring of the binding of the two
targets (Figure 4C). We found that RRM1 binds to elav and
nrg targets with apparently similar afﬁnities, since the ratio
between the two RNAs remains constant. RRM3 shows an
overall lower RNA afﬁnity than RRM1 and, contrary to
RRM1, exhibits a preference for the nrg target (Figure 4C).
Again, RRM2 does not show RNA-binding activity. Although,
as has been seen for other ELAV-like proteins (19) independ-
ent ELAV RRMs have a lower afﬁnity for their RNA
targets than the whole ELAV protein, their binding
speciﬁcity recapitulates that of the whole protein (Figures 2
and 4), with RRM1 being the most effective individual
RNA-binding domain.
FNE shares common RNA targets with ELAV
We described previously an elav paralogue (fne) whose prod-
uctisconcentratedinthecytoplasm ofneurons,where itsover-
expression causes a decrease in stable elav transcript levels
(8). Both ELAV and FNE show high afﬁnity for polyuridylic
acid, but ELAV is more versatile and also binds to single- and
double-stranded DNA (8). We tested whether the interaction
between the two genes could rely upon interaction of their
Figure 2. ELAV specifically binds discrete sequences. (A) Labelled RNAs (1.5–3 nM) were used in shift assays with GST-ELAV protein, concentration in nM as
indicated. All panels from the same experiment. The first protein–RNA complexes formed (sequentially E1, E2 and E3) are indicated. (B) Binding curve between
GST–ELAV protein and discrete RNA species, all experiments performed in parallel with the same protein batch. (C) Sequence of the target RNAs tested in
Figure 2A. SSE, the region common to the RNAs from cluster 1 (Figure 1) is underlined. A diagram of the RNAs with the relative overlaps is on the right. RNA
symbolsandcoordinatesinthescalefromFigure1.SSE1F,coordinates12310–12429inelav30-UTR.SSE1R,reversecomplementtoSSE1F.SSE1FD,coordinates
12310–12374 in elav 30-UTR. EXS6, RNA derived from a neuroglian intron (14). These RNAs also include sequences encoded by the plasmid, respectively,
GGGCGAAUUGGGGAUU in 50 and, except for SSE1FD, AUCACUAGUGC in 30. C1/SSE10 and 11 (Figure 1).
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this possibility, shift assays show that, similarly to ELAV,
FNE speciﬁcally binds to elav and nrg RNA targets
(Figures 2A and 5A). Furthermore, as shown when providing
nrg and elav RNA targets simultaneously in shift assays, both
FNE and ELAV bind the two RNAs with apparently similar
afﬁnities (Figure 5B). As for ELAV, we observe reproducible
patterns of bands presumably corresponding to sequentially
formedcomplexesasFNEconcentrationincreases(Figure5A).
GST–FNE7,afusionmissingthe72N-terminalaminoacidsof
RRM1, also shifts elav RNA (SSE1F) and sequential com-
plexes visible by gel shifts are formed (data not shown).
We performed binding assays by mixing ELAV and FNE
proteins to determine if RNA binding by one protein affects
binding by the other. The impact of the progressive addition of
ELAV on FNE–RNA interactions (Figure 5C) reveals good
consistency between the intensity of the shift and the total
protein concentration, with the progressive addition of
ELAV causing an increased shift of the RNA, (Figures 2A,
5A and C). Thus, binding of one protein neither inhibits nor
favours the binding of the other.
At high protein concentrations, high molecular weight com-
plexes are formed (Figure 5D) We noticed that the migration
of the complexes formed at equimolar ELAV and FNE con-
centrations (80 nM each) is intermediate to the migration of
FNE–RNA complexes and ELAV–RNA complexes at 160 nM
protein concentrations, respectively. This indicates that hybrid
complexes including the RNA(s) and both ELAV and FNE
can be formed.
Figure 3. Competition study of ELAV binding to SSE. Shift assays with
labelled SSE1F RNA (3 nM) and specific unlabelled RNA competitors. The
RNAs were mixed and denatured prior to the addition of GST–ELAV (con-
centrationasindicated).(A)2-Folddilutionsofcompetitors[5–0.15mgpoly(U)
and poly(A), average size 600mers, Sigma P9528 and P9403]: 400·, 200·,
100·,5 0 ·,2 5 · and 12.5· excess molarity compared with SSE1F. (B) 5-Fold
dilutions of competitors (10 mg to 3.2 ng). SSE, SSE C: 25000·, 5000·,
1000·, 200·,4 0 · and 8· excess molarity compared with SSE1F, and poly(U)
(as in Figure 3A): 800·, 160·,3 3 ·,7 ·, 1.3· and 0.26· excess molarity com-
pared with SSE1F. SSE, AUUUUUAUUUGUUAUUUUUU; SSE C, SSE
with the substitution of G by C.
Figure 4. ELAV RRMs show distinct RNA-binding properties. (A) Diagram of the fusion proteins. Wild-type ELAV, full-size ELAV protein. The boxed area
correspondstotheQA-richN-terminaldomain.TheportionsofELAVfuseddownstreamoftheGSTdomaininthefusionsareshownbelow.RRM,RNArecognition
motif. The pairs of vertical bars correspond to the signature motifs RNP-CS2 and RNP-CS1. (B) Binding assays between GST-fusions and resin-conjugated
homoribopolymers, as indicated. (C) Shift assays with a mixture of EXS6 and SSE1FD RNAs (1.5 nM each) and GST–RRM fusions (concentrations as indicated).
All panels from the same experiment.
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produced from the elav locus
The stable transcript pattern of elav is complex and dynamic,
in contrast with the fact that only one form of protein is
produced. Neither the gene sequence nor functional data
predict the existence of alternative protein forms. It thus
seems probablethattheobservedtranscriptcomplexityreﬂects
elav post-transcriptional regulation. We have shown previ-
ously that the level of ELAV protein produced in neuron is
tightly regulated and independent of gene dosage (36). We
wished to determine how the binding of ELAV to the SSE-
binding site in the elav 30-UTR could contribute to gene regu-
lation, and for that purpose we examined the structure of
transcripts produced from the elav locus.
Although a complete 2.5 kb functional elav cDNA (cDNA-
1/LD33076, Figure 6A) has been identiﬁed, all the elav RNA
detected on northern blots with single-stranded antisense
probes corresponding to cDNA-1 are larger than 5 kb (8).
To gain insight into the structure of the multiple forms of
elav RNA, we screened cDNA libraries (from Drosophila
heads and embryos) (8). In addition, cDNAs identiﬁed by
the Berkeley Drosophila Genome Project (38) were examined,
and we completed the sequencing of those that we suspected
might differ from the original coding elav cDNA-1
(Figure 6A).
The larger elav transcripts are absent as full-size cDNAs
from the cDNA libraries, but partial cDNAs allow the (not
necessarily exhaustive) identiﬁcation of four alternative poly-
adenylation sites and alternative exon/intron boundaries
(Figure 6A). Surprisingly, several forms of non-coding RNA
exist, that we separate into two categories. First, those that
differ from cDNA-1 by the exon(s), upstream of the elav ORF
(Figure 6A), indicating that one level of regulation of elav
expression is mediated by the regulation of the splicing event
that generates the initiatingATG. Second, we identiﬁed a form
of cDNA (RE58603) alternative to the coding cDNA-1, which
includes an alternative non-coding 30 terminal exon
(Figure 6A). It seems that a primary transcript that matures
in multiple fashions is produced from the elav locus. Pro-
cessing results in either RNA capable of producing ELAV
protein, or on the contrary on abortive RNAs, a mechanism
that could be very efﬁcient at regulating ELAV protein levels.
The ELAV best binding site in the elav 30-UTR maps to
a non-coding alternative exon
ELAV binds to a site, SSE, retained in RE58603 (Figure 6A).
This non-coding RE58603 cDNA differs from the coding
cDNA-1 by the substitution of a non-coding 30 exon that
replaces the 30 coding 30 exon of cDNA-1. This suggests a
simple model, whereby when ELAV levels pass a given
threshold, the protein binds to its own 30-UTR (at SSE) in
the pre-mRNA, favouring the generation/accumulation of
non-coding RNA (RE58603) versus that of a coding RNA
(LD33076).
To test this hypothesis, we ﬁrst determined by northern blot
the pattern of expression of RNAs including the third exon
Figure 5. FNE, a protein of the ELAV family, shares common RNA targets with ELAV. (A) Labelled RNAs (1.5–3 nM) were used in shift assays with GST-FNE2
protein, concentration in nM as indicated. The first protein–RNA complexes formed (sequentially F1, F2 and F3) are indicated. (B) Shift assays with a mixture of
EXS6 RNA (1.5 nM) and SSE1FD RNA (2.5 nM) with GST–FNE2 or GST–ELAV fusions (concentrations as indicated). (C and D) Shift assays of SSE1F RNA
(3 nM) with mixtures of ELAV and FNE proteins. All panels from the same experiment.
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Figure 6A) in the elav RNAs. Surprisingly, most of these
RNAs are the same as those detected by an antisense elav
ORF probe, although the 3 kb RNA corresponding to
RE58603 itself is not detected (Figure 6B). Clearly, complex
transcripts that were not identiﬁed as full-size cDNA clones
and that include large portions of the elav locus are produced,
making it impossible to distinguish between the RNA with a
coding exon 3 and a proper ATG (type cDNA-1) versus its
non-coding counterpart including a non-coding alternative
exon 3 (type LD33076).
We thus reasoned that all the functional elav RNA, includ-
ing hypothetical forms that would differ from the cDNA-1
type by including, for instance, an extended 30-UTR, must
share the common splicing event that generates the ATG ini-
tiation codon. We identiﬁed these by RT–PCR using the EX2F
and EX3R primers, in parallel with the alternative non-coding
transcript of the RE58603 type, that were detected with
the EX2F and EX4R pair of primers (Figure 6A and C). As
predicted by our model, the coding transcript accumulates
from the time neurons start to be born ( 5 h of development)
and peaks  8–12 h of development, shortly before the birth of
the last embryonic neurons. In contrast, non-coding transcripts
ﬁrst appear coincidentally with the peak of the coding tran-
script (8–12 h). Their level rises and plateaus until the end of
embryonic development.
Figure 6. Alternativepolyadenylationandsplicingattheelavlocus.(A)Thelocusisshownasacontinuousline(B,BamHI;E,EcoRI;H,HindIII),withascaleinkb
atthebottomof(A),asinFigure1.TheelavORFisshownasastripedbox(exceptfortheAoftheinitiatorcodon)startingatnt7099andfinishingat8549.TfSandTfL
asinFigure1.ThestructureofelavmRNAs,derivedfromthecompletesequencingofcDNAclones,isindicated.AllcDNAswereobtainedfromembryoniclibraries,
exceptforcDNA-16handcDNA3hwhichwerefromadultheadlibraries.Allfourpolyadenylationsites(pA)areincludedinthepreviouslyreportedTfLminigenes,
whichareexpressednormally(36).Onlythemost50 poly(A)siteisincludedinTfSminigenesthatareabletoprovideelavfunctionbutaremis-regulated(36).Similar
totheTfSminigenes,LD33076/cDNA-1issufficienttorescueelavnullfunctioncompletelywhenunderthecontrolofelav50-UTRsequencesanda30 tubulintrailer,
butitismis-regulated(36).NotethatthecodingcDNALD33076includesa54Alongpoly(A)tailandusesthepA1polyadenylationsite.Itsstructureisidenticalto
that of cDNA1 which has been hypothesized previously to possess a truncated 30 end because of (i) its size discrepancy with the elav stable transcripts detected on
northern blots and (ii) the knowledge that elav transcripts extendeddownstream.The position of the SSE elav-binding site and the primers EX2F,EX3R and EX4R
used in the RT–PCR experiments of (C) are indicated. (B) Developmental analysis of elav transcripts. The filter was first hybridized with an antisense probe
correspondingtoexon3ofRE58603(upperpanel)andthenre-hybridizedwithaprobecorrespondingtoexon3ofcDNA-1(lowerpanel),andfinallytoanantisense
RP49probeasaloadingcontrol.AnantisenseprobecorrespondingtotheincompleteadultcDNA-16h(betweenpA3andpA4)doesnotdetectanyRNAonnorthern
blots,butitdetectsthecentralnervoussystemofembryosbyinsituhybridization(datanotshown),asexpectedforanelavtranscript.Molecularweightsontheright.
E, embryonic stages with the window of development specified; L1 and L3, first and third instar larvae, respectively. (C) RT–PCR for the detection of coding
transcripts(EX2FplusEX3Rprimers,Figure6A),alternativenon-codingtrancriptsoftheRE58603type,(EX2FplusEX4Rprimers,Figure6A),andRP49usedasa
controlforRNAabundance.Windowsofembryonicdevelopmentasindicated.ThecontrollaneshowsthePCRproductsobtainedbyamplificationofcDNAclones:
cDNA-1 in the case of EX2F plus EX3R primers, and RE58603 in the case of EX2F plus EX4R.
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ELAV binds a site in the elav 30-UTR that resembles
binding sites already identified in nrg and ewg
ELAV-binding sites have been reported in regulated introns of
nrganderectwing(ewg)(14,16).InnrgRNA, theyare deﬁned
as long tracts including at least two 8–10 nt-long U-rich
stretches. In ewg RNA, ELAV-binding sites consist of
AU-rich elements including three to four tandemly repeated
A(U4–6) sequences. Our approach allowed us to map the
ELAV best binding site in its RNA to a shorter U-rich
sequence that is only 20 nt long (SSE). We found that the
afﬁnity of ELAV for a 65 nt long RNA including SSE is in the
nanomolar range, similar to that of ELAV for a 164 nt long
RNA derived from ewg proposed to bind several ELAV
molecules (16). It is also similar to ELAV afﬁnity for an
RNA including the 114 nt long EXS6 from nrg RNA that
cross-links to ELAV (this paper).
Competition experiments highlight the higher afﬁnity
of ELAV for the SSE site than for a mutant version of the
site where a C replaces the single G. Thus, the interac-
tion between ELAV and the RNA depends in part upon
recognition of speciﬁc bases, not just of the phosphate
sugar-backbone.
Sequence analysis of 500 nt framing SSE with the Stem
Loop program as well as attempts to identify secondary struc-
tures with the programs Mfold and PlotFold (GCG Wisconsin
Package) in the 65 nt long SSE1FD RNA failed to identify any
secondary structure with base pairing of SSE (data not shown).
ELAV thus binds ssRNA, reminiscent of the binding of the
SXL and HuD proteins, whose two RRMs share extensive
structural similarity with ELAV RRM1 and RRM2 and
which also bind ssRNA with no base pairing (23,24).
An ELAV-binding site with a U-rich sequence and a low
dissociation constant with ELAV was thus identiﬁed in the
elav 30-UTR. The characteristics of this site resemble those of
the previously identiﬁed ELAV targets, supporting the validity
of the binding site that we identiﬁed in the elav 30-UTR, and
thus our model that elav autoregulation depends upon direct
binding of ELAV to the 30-UTR of elav RNA.
ELAV RRM1 and RRM3 bind RNA on their
own with different specificities
ELAV protein and its homologues contain three conserved
RNA-binding domains. Mutations in any of the three domains
abolish ELAV function. However domain swap experiments
(with RRMs from the Drosophila paralogue RBP9, the Droso-
phila relative SXL or the human orthologue HuD) showed that
chimeric ELAV proteins with substituted RRM3, but not
RRM1 and/or RRM2, are functional (40).
We evaluated the binding properties of individual RRMs to
determine if distinct RRMs are responsible for the speciﬁc
target recognition of nrg and elav-binding sites. We found
that both RRM1 and RRM3 are capable of signiﬁcantly bind-
ing RNA on their own, with RRM1 showing a higher afﬁnity
than RRM3. No RNA-binding activity was detected for RRM2
with the targets that we tested (nrg, elav sites, this paper; and
the OL RNA, data not shown), even using different batches of
proteins. We cannot exclude the possibility that the ELAV–
RRM2 fusion protein, in spite of the fact that it is abundantly
and stably produced, may be non-functional, possibly owing to
altered folding. Another alternative is that ELAV–RRM2 can
bind RNA only when another partner RRM is available, as in
the case of HuD or HuC, whose second RRMs increases the
afﬁnity of RRM1 for an AU-rich sequence and stabilizes the
complex (21,26).
Conserved residues between HuD and SXL interact with
different bases in their different targets [U(A/U)UUUAUUUU
for HuD and UGUUUUUUUUU for SXL] (23), and it thus
seems possible that the same ELAV RRMs are involved in nrg
and elav target recognition. However, our binding assay invol-
ving one protein and two binding sites shows that RRM1 and
RRM3 display different relative afﬁnities for the nrg and elav
RNA-binding sites. As a correlate, if the properties of indi-
vidual RRMs are maintained in the complete protein, ELAV
binding with speciﬁc RNAs may rely upon particular interac-
tions with different RRMs. In vivo, it is conceivable that the
complexes might interact with different sets offactors andthus
enter distinct pathways of post-transcriptional processing,
depending upon which RRM is involved in RNA contact
(see below).
ELAV and FNE
The neuronal protein FNE is encoded by an elav paralogue,
and the expression of the two genes is interconnected.
In particular fne over-expression causes a decrease of elav
(and fne) stable trancript levels, suggesting feedback regula-
tion (8). We showed that FNE and ELAV both can bind the
elav SSE-binding site independently, and it has been shown
that the two proteins can interact directly, since they have
been identiﬁed in a large-scale two-hybrid screen of Droso-
phila proteins as high conﬁdence partners (42). These two
properties could be involved in the feedback regulation.
FNE could regulate elav by binding to elav RNA directly
or FNE could titrate ELAV, both antagonizing the occupation
of RNA-binding sites by ELAV. This would require that
ELAV, which is predominantly nuclear, and FNE, which is
predominantly cytoplasmic, would be present in the same
cellular compartment, at least transiently. HuR, an apparently
nuclear human orthologue of ELAV shuttles between the
nucleus and the cytoplasm (41).
We observed that, when mixing FNE and ELAV with RNA,
binding complexes with RNA including both ELAV and FNE
are formed. One explanation for this observation is that a low
afﬁnity-binding site is also present in the RNA target and
bound at high protein concentrations, allowing bridging of
protein complexes via the RNA. But, since the proteins inter-
act directly (42), it seems more probable to us that direct
protein–protein interaction, before or after RNA binding, is
responsible for the formation of these complexes.
The ELAV best binding site in the elav 30-UTR
maps to a non-coding alternative exon
The processes required for the generation of mature mRNAs
are intimately linked [reviewed in (43,44)] and depend upon
cis-regulatory regions scattered over the entire length of an
RNA. Our analysis of elav cDNAs provides some insights into
the remarkable complexity of the transcripts, presumably
reﬂecting post-transcriptional regulation.
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scripts whose size far exceeds that of the only coding elav
RNA so far identiﬁed. Such a situation was ﬁrst reported in the
case of the gene suppressor of white apricot, which encodes an
SR-like protein, and produces mature short transcripts that are
detected only brieﬂy during development, while larger poly-
adenylated unspliced RNAs are the only detected transcripts
during most of development (45).
In addition, four polyadenylation sites were identiﬁed in
elav, as was reported for some of the vertebrate Hu loci,
where they have been proposed to play speciﬁc roles in
post-transcriptional regulation (46). Indeed, this type of organ-
ization in the 30 end of transcripts is not rare, since 28.6% of
8700 analysed human 30-UTRs contain two to four poly-
adenylation sites (47).
Although a model where ELAV binding in the proximity of
polyadenylation sites and slowing the recruitment of cleavage
factors or of poly(A) polymerase can explain the data reported
in the case of nrg and ewg (14,16), it does not ﬁt in the case
of the elav gene. The sequences of ELAV-binding sites are
not dramatically different, but they differ in their nature.
ELAV binding to nrg and ewg RNAs occurs in alternative
30 introns and is responsible for the generation of alternative
forms of proteins, while binding to elav RNA occurs in an
alternative non-coding 30 exon and does not cause protein
diversity. The SXL protein, whose two RRMs share extensive
structural similarity with ELAV also possesses several distinct
functions, in this case at the level of splicing and of translation
regulation.
We showed here that ELAV binds to a site retained in a non-
coding elav RNA (RE58603), that differs by the inclusion of
an alternate 30-terminal exon from the functional form of elav
mRNA (LD33076). Our RT–PCR data are in agreement with
our proposed model hypothesizing that the coding transcript is
produced as long as the level of ELAV protein remains below
a given threshold and thus unbound to SSE. The non-coding
transcript is alternatively produced by alternative choice of the
terminal exon/polyadenylation site once ELAV protein level
passes this threshold and binds SSE. This model provides a
mechanism for the regulation of ELAV protein level, which
we have genetically shown to be critical and dependent upon
the elav 30-UTR (36).
The dual RNA-binding mechanism, suggested by the spe-
ciﬁc preferences for different RNAs by individual RRMs,
might be linked to dual functional properties, for instance
via association with different additional partner proteins,
which might include FNE. Future work will aim to examine
this possibility in order to identify the mechanism(s), such as
regulation of exon deﬁnition and/or cleavage/polyadenylation
responsible for elav regulatory functions.
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